2022 Annual Meeting

Session: Control Strategies in Pharmaceutical Development and Manufacturing I

Chair

Co-Chair

Marton, C., Bristol Myers Squibb

Presentations

12:30 PM

(138a) Development of an Adsorbent Treatment Workflow for Impurity Removal

12:51 PM

(138b) Development and Control of a Late-Stage API Crystallization Via Kinetics Modeling and Controlled Crystallization

01:12 PM

(138c) Control of Ritter Side Products Via Reaction Engineering and Kinetic Modeling to Enable Robust Scale-up

01:33 PM

(138d) Wet Milling of Mefenamic Acid for Seed Generation: Model-Driven Size Reduction for Maximizing Yield

01:54 PM

(138e) Process Development and Characterization of an Acutely Hazardous Reaction through Data Rich Experimentation

02:15 PM

(138g) A Surrogate-Based Multi-Objective Optimization with Adaptive Sampling for Advanced Pharmaceutical Manufacturing